Healthcare & Life Sciences
Seaport Therapeutics
United Statesseaporttx.com
Seaport Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Pre-IPO, 2 tracked investors.
IPOpre-ipo
pre-ipo
Stage
2018
Founded
2
Investors
About Seaport Therapeutics
Based in the United States, Seaport Therapeutics is a startup founded in 2018. Its most recent tracked round is Pre-IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Seaport Therapeutics develops new medicines for patients with depression, anxiety, and other neuropsychiatric disorders using its Glyph™ platform to improve drug delivery to the brain and reduce side effects.
Explore Seaport Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.